GRANULES INDIA
|
The Current P/E Ratio of GRANULES INDIA is 25.30.
| Share Price | ₹568.6 | Feb 17,2026 |
| Market Cap | ₹13,799.9 Cr | |
| Earnings-TTM | ₹545.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 25.30x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of GRANULES INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,799.9 Cr] as on Feb 17,2026
(/) Earnings [ ₹545.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 25.30x ]
Thus, for GRANULES INDIA , the investors are currently willing to pay 25.30 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GRANULES INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of GRANULES INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of GRANULES INDIA
PE Ratio Performance Analysis for GRANULES INDIA
- GRANULES INDIA 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 18.99x.
- GRANULES INDIA 's operated at median p/e ratio of 18.4x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, GRANULES INDIA 's p/e ratio peaked in Mar2024 at 25.71x.
- GRANULES INDIA 's p/e ratio hit its five-year low in Mar2023 of 13.62x.
How does GRANULES INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| GRANULES INDIA | 545.48 | 25.30 | 13,799.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 37.46 | 412,062.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 66.23 | 164,192.0 |
| CIPLA LTD | 4,544.70 | 23.88 | 108,513.0 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 63.44 | 144,129.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 19.47 | 107,250.0 |
| MANKIND PHARMA LTD | 1,796.65 | 47.42 | 85,198.8 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 18.49 | 91,240.3 |
| LUPIN LTD | 4,669.18 | 22.00 | 102,734.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 19.58 | 68,804.7 |
| ABBOTT INDIA LTD | 1,524.13 | 36.95 | 56,313.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs GRANULES INDIA 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.49x |
| Max industry PE | 66.23x |
| Median industry PE | 25.30x |
| Average industry PE | 34.57x |
You may also like the below Video Courses